Announcements & Circulars-Consun Pharmaceutical Group

Home
Approach To Consun
Company profile Management team Business Structure
Product Center
Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
R&D Innovation
R&D Platform R&D Team R&D Technology R&D Achievements
Investor Relations
Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact

中文

Investor Relations

Corporate Governance
Announcements & Circulars
Regular Reports
Documents available for inspection
IR Contact

Announcements & Circulars

2021-01-04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
2020-12-16 CHANGE OF ADDRESS OF REGISTERED OFFICE AND PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
2020-12-14 Next Day Disclosure Return
2020-11-30 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
2020-11-18 Next Day Disclosure Return
2020-11-17 Next Day Disclosure Return
2020-11-18 Next Day Disclosure Return
2020-11-17 Next Day Disclosure Return
2020-11-16 Next Day Disclosure Return
2020-11-13 Next Day Disclosure Return

Home Previous 31 32 33 34 353637 38 39 40 41 ...79 Next Last

Approach To Consun
Product Center
R&D Innovation
Investor Relations

400-930-1681

总机：（86）20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

Consun
Health Station
Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号 Design: uweb